NCT07340164 2026-01-14
TROY
Yonsei University
Phase 2 Not yet recruiting
Clinical Trials
6 trialsNCT06859775 2025-06-06
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2 Recruiting
NCT04868708 2025-03-04
A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer
Akeso
Phase 2 Completed
NCT04015739 2022-08-17
BOLD
ARCAGY/ GINECO GROUP
Phase 2 Unknown
NCT00846612 2019-09-30
Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer
NYU Langone Health
Phase 1 Completed
NCT01031381 2016-08-30
RADBEV
University of Pittsburgh
Phase 2 Completed